Status:
TERMINATED
Personalised Program for Women Treated for Hodgkin Disease
Lead Sponsor:
Institut Paoli-Calmettes
Conditions:
Hodgkin Disease
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
After treatment for Hodgkin disease, secondary cancer, in particular breast cancer induced by treatment, are the first cause of death. The investigators will estimate the risk to develop breast cance...
Eligibility Criteria
Inclusion
- women \> 18 years
- treated for Hodgkin disease
- signed informed consent
- high risk of breast cancer
Exclusion
- patients unable to have a regular follow-up
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2026
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT01188915
Start Date
July 1 2010
End Date
July 1 2026
Last Update
October 14 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
François EISINGER, PhD
Marseille, France, 13009